(Q38313784)

2 September 2017

title

Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus (English)

1 reference

2 September 2017

0 references

Tae-Young Ha

1

1 reference

2 September 2017

Young-Seok Kim

2

1 reference

2 September 2017

Chun Hwa Kim

3

1 reference

2 September 2017

Hyo-Sun Choi

4

1 reference

2 September 2017

Jin Yang

5

1 reference

2 September 2017

Soo Hyun Park

6

1 reference

2 September 2017

Dae Hoon Kim

7

1 reference

2 September 2017

Jae-Keol Rhee

8

1 reference

2 September 2017

publication date

30 July 2013

1 reference

Archives of Pharmacal Research

2 September 2017

published in

1 reference

2 September 2017

volume

37

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

671-678

1 reference

A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

Triggering and amplifying pathways of regulation of insulin secretion by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

G protein-coupled receptors and insulin secretion: 119 and counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

The therapeutic potential of GPR119 agonists for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

Type 2 diabetes: new genes, new understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

Type 2 diabetes: principles of pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0209-0

10.1007/S12272-013-0209-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1028661910

0 references

1 reference